Should Weakness in Repligen Corporation's (NASDAQ:RGEN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?Simply Wall St • about 1 month ago
With its stock down 7.9% over the past week, it is easy to disregard Repligen (NASDAQ:RGEN). However, the company's...
Share to Feed
Repligen Co. (NASDAQ:RGEN Get Free Report) has been given a consensus rating of Moderate Buy by the nine brokerages that are currently covering the firm, Marketbeat.com reports...
WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax...
Repligen Co. (NASDAQ:RGEN Free Report) Zacks Research dropped their Q1 2024 earnings per share (EPS) estimates for Repligen in a note issued to investors on Wednesday, March 13th...
Repligen Co. (NASDAQ:RGEN Free Report) Research analysts at Zacks Research dropped their Q1 2024 earnings per share estimates for shares of Repligen in a research note issued to...
Repligen Co. (NASDAQ:RGEN Get Free Report) VP Ralf Kuriyel sold 3,517 shares of the firms stock in a transaction dated Monday, March 11th. The shares were sold at an average price of...
Repligen Co. (NASDAQ:RGEN Get Free Report) VP Ralf Kuriyel sold 3,517 shares of the firms stock in a transaction dated Monday, March 11th. The shares were sold at an average price of...
Comerica Bank grew its position in shares of Repligen Co. (NASDAQ:RGEN Free Report) by 1,259.1% during the third quarter, according to its most recent Form 13F filing with the Securities...
Related Stocks: RGEN...
Profund Advisors LLC trimmed its holdings in shares of Repligen Co. (NASDAQ:RGEN Free Report) by 14.0% during the third quarter, according to its most recent 13F filing with the Securities...